Trial
NCT04318327
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Multiple Myeloma
Intervention
PHE885
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-01